Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma

1. Ludwig, H.
2. Viterbo, L.
3. Greil, R.
4. Masszi, T.
5. Spicka, I.
6. Shpilberg, O.
7. Hajek, R.
8. Dmoszynska, A.
9. Paiva, B.
10. Vidriales, M.-B.
11. Esteves, G.
12. Stoppa, A.M.
13. Robinson Jr., D.
14. Ricci, D.
15. Cakana, A.
16. Enny, C.
17. Feng, H.
18. Van De Velde, H.
19. Harousseau, J.-L.